Public Health and “Counterfeit” Medicines: The Role of the World Health Organization
Introduction
The normative and policy-setting functions of the World Health Organization (âWHOâ) have been substantially influenced by the differences of opinion within WHOâs membership about the impact of trade and intellectual property (âIPâ) rules on public health. In particular, WHO members differ as to the organizationâs role in addressing the perceived failure of the pharmaceutical market to generate safe and affordable medicines for diseases predominantly affecting developing countries.